Intranasal Ketamine Reduces Pain in Children Hospitalized for Migraine
A single-center study showed that intranasal ketamine effectively reduced pain in children with migraine from hospital admission to discharge.
Pain Management Information Center
Drug Therapies Evaluated for Pediatric Migraine Prophylaxis
There is limited evidence supporting the prophylactic use of pharmacological therapies for the prevention of migraine in pediatric patients, according to the findings of a recently published systematic review and network meta-analysis.
Author Conflicts of Interest May Influence Cannabidiol Conclusions
Supportive conclusions seen in more studies with vs without CBD-related industry funding.
FDA Approves OTC Combination of Ibuprofen and Acetaminophen
Each caplet contains 125mg of Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) and 250mg of acetaminophen and is indicated for adults and children 12 years of age and older.
The Impact of Weight Loss on Migraine Characteristics in Patients With Obesity
Among patients with obesity and migraine, weight loss is associated with reduction of migraine frequency, pain severity, and attack duration and disability.
Nonpharmaceutical Interventions Aid Low Back Pain
Movement-based mind-body interventions could be effective alternatives to drugs, surgery, injections.
Kratom Seems Safe for Pain, Anxiety, Opioid Withdrawal
Kratom most commonly used daily; few serious adverse events self-reported among users.
Ubrogepant Works Quickly to Relieve Acute Migraine Pain
Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.
Overdose, Relapse After Buprenorphine Discontinuation High
The longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes.
Evidence Supports Use of High-Dose Aspirin for Migraine
High-dose aspirin safe, effective for acute migraine; low-dose aspirin can prevent recurrent attacks.
Addressing Two Public Health Epidemics: Suicide and Opioid Addiction
Traditionally, suicide and overdose prevention in opioid use disorder involve stratifying risk based on certain demographic and clinical factors.
Advance Practice Providers Still Encounter Barriers to Prescribing Buprenorphine for Opioid Use Disorder
Researchers sought to describe the practice patterns of NPs and PAs, understand the barriers these providers face in providing buprenorphine treatment, and compare them with their physician counterparts and across varying levels of practice autonomy.
CBD: A Primer for the PCP
Clinicians are routinely asked by their patients if CBD products are safe and effective, but research is lagging behind public acceptance.
Type of Initial Provider Consulted for New-Onset LBP May Influence Opioid Use
Patients with new-onset low back pain who initially consulted a chiropractor or physical therapist vs a primary care physician were found to have reduced risk for long-term opioid use.
Early Access to Chiropractors, PTs Tied to Decreased Long-Term Opioid Use
Odds of short- or long-term opioid use higher for initial visits with physicians for low back pain.
Impact of Tightening Opioid Regulations in Patients With Chronic Pain
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
Clinical Guideline on Injectable Opioid Agonist Treatment for Severe Opioid Use Disorder
The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline on the use of injectable opioid agonist treatment for opioid use disorder.
Challenges Associated With the Use of CBD, Hemp Oils in Chronic Pain, Opioid Addiction
There are a number of challenges associated with the use of cannabidiol and hemp oils in pain management.
Consensus on Recommendations for End-of-Life Pain Management for the Critically Ill in the ICU
The majority of existing clinical guidelines and consensus statements on pain management at the end of life in the intensive care unit agree on a set of recommendations that include the use of high doses of opioid.
Primary Care Appointment Time Impacts Prescribing of Opioids
Appointment time and running behind schedule significantly affect likelihood of opioid prescription.
Want to read more?
Please login or register first to view this content.
Next post in Pain Management Information Center
